127 related articles for article (PubMed ID: 10830785)
1. Metallothionein inhibits myocardial apoptosis in copper-deficient mice: role of atrial natriuretic peptide.
Kang YJ; Zhou ZX; Wu H; Wang GW; Saari JT; Klein JB
Lab Invest; 2000 May; 80(5):745-57. PubMed ID: 10830785
[TBL] [Abstract][Full Text] [Related]
2. Changes in copper and zinc status and response to dietary copper deficiency in metallothionein-overexpressing transgenic mouse heart.
Kang YJ; Jiang Y; Saari JT
J Nutr Biochem; 2007 Nov; 18(11):714-8. PubMed ID: 17707633
[TBL] [Abstract][Full Text] [Related]
3. Antiapoptotic effect and inhibition of ischemia/reperfusion-induced myocardial injury in metallothionein-overexpressing transgenic mice.
Kang YJ; Li Y; Sun X; Sun X
Am J Pathol; 2003 Oct; 163(4):1579-86. PubMed ID: 14507664
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes.
Wang GW; Klein JB; Kang YJ
J Pharmacol Exp Ther; 2001 Aug; 298(2):461-8. PubMed ID: 11454906
[TBL] [Abstract][Full Text] [Related]
5. Alterations in hypertrophic gene expression by dietary copper restriction in mouse heart.
Kang YJ; Wu H; Saari JT
Proc Soc Exp Biol Med; 2000 Mar; 223(3):282-7. PubMed ID: 10719841
[TBL] [Abstract][Full Text] [Related]
6. Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse.
Mori T; Chen YF; Feng JA; Hayashi T; Oparil S; Perry GJ
Cardiovasc Res; 2004 Mar; 61(4):771-9. PubMed ID: 14985074
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
[TBL] [Abstract][Full Text] [Related]
8. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.
Zhou G; Li X; Hein DW; Xiang X; Marshall JP; Prabhu SD; Cai L
J Am Coll Cardiol; 2008 Aug; 52(8):655-66. PubMed ID: 18702970
[TBL] [Abstract][Full Text] [Related]
9. Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases.
Kang YJ; Zhou ZX; Wang GW; Buridi A; Klein JB
J Biol Chem; 2000 May; 275(18):13690-8. PubMed ID: 10788488
[TBL] [Abstract][Full Text] [Related]
10. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.
Cai L; Wang Y; Zhou G; Chen T; Song Y; Li X; Kang YJ
J Am Coll Cardiol; 2006 Oct; 48(8):1688-97. PubMed ID: 17045908
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.
Sun X; Zhou Z; Kang YJ
Cancer Res; 2001 Apr; 61(8):3382-7. PubMed ID: 11309296
[TBL] [Abstract][Full Text] [Related]
12. Regression of copper-deficient heart hypertrophy: reduction in the size of hypertrophic cardiomyocytes.
Zhou Z; Johnson WT; Kang YJ
J Nutr Biochem; 2009 Aug; 20(8):621-8. PubMed ID: 19027282
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes.
Horio T; Nishikimi T; Yoshihara F; Matsuo H; Takishita S; Kangawa K
Hypertension; 2000 Jan; 35(1 Pt 1):19-24. PubMed ID: 10642269
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of hypoxia/reoxygenation-induced apoptosis in metallothionein-overexpressing cardiomyocytes.
Wang GW; Zhou Z; Klein JB; Kang YJ
Am J Physiol Heart Circ Physiol; 2001 May; 280(5):H2292-9. PubMed ID: 11299233
[TBL] [Abstract][Full Text] [Related]
15. Pressure-independent enhancement of cardiac hypertrophy in atrial natriuretic peptide-deficient mice.
Feng JA; Perry G; Mori T; Hayashi T; Oparil S; Chen YF
Clin Exp Pharmacol Physiol; 2003; 30(5-6):343-9. PubMed ID: 12859424
[TBL] [Abstract][Full Text] [Related]
16. Effect of AT2 blockade on cardiac hypertrophy as induced by high dietary salt in the proatrial natriuretic peptide (ANP) gene-disrupted mouse.
Angelis E; Tse MY; Adams MA; Pang SC
Can J Physiol Pharmacol; 2006 Jun; 84(6):625-34. PubMed ID: 16900247
[TBL] [Abstract][Full Text] [Related]
17. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure.
De Windt LJ; Lim HW; Taigen T; Wencker D; Condorelli G; Dorn GW; Kitsis RN; Molkentin JD
Circ Res; 2000 Feb; 86(3):255-63. PubMed ID: 10679475
[TBL] [Abstract][Full Text] [Related]
18. Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice.
Franco V; Chen YF; Feng JA; Li P; Wang D; Hasan E; Oparil S; Perry GJ
Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):773-9. PubMed ID: 16922805
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of metallothionein reduces diabetic cardiomyopathy.
Liang Q; Carlson EC; Donthi RV; Kralik PM; Shen X; Epstein PN
Diabetes; 2002 Jan; 51(1):174-81. PubMed ID: 11756338
[TBL] [Abstract][Full Text] [Related]
20. Local atrial natriuretic peptide signaling prevents hypertensive cardiac hypertrophy in endothelial nitric-oxide synthase-deficient mice.
Bubikat A; De Windt LJ; Zetsche B; Fabritz L; Sickler H; Eckardt D; Gödecke A; Baba HA; Kuhn M
J Biol Chem; 2005 Jun; 280(22):21594-9. PubMed ID: 15793309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
